Latest Breaking News On - Heron therapeutics - Page 5 : comparemela.com

Heron Therapeutics Inc (HRTX) Q1 2024 Earnings Overview: Surpasses Revenue Estimates

Heron Therapeutics Inc (HRTX) Q1 2024 Earnings Overview: Surpasses Revenue Estimates
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Heron-therapeutics-inc
Crosslink-life-sciences
Financial-performance
Heron-therapeutics
Financial-metrics
Investor-day

HRTX Stock Earnings: Heron Therapeutics Beats EPS, Beats Revenue for Q1 2024

HRTX Stock Earnings: Heron Therapeutics Beats EPS, Beats Revenue for Q1 2024
biztoc.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from biztoc.com Daily Mail and Mail on Sunday newspapers.

Heron-therapeutics
Place-earnings

Pekin Hardy Strauss Inc. Lowers Stock Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX)

Pekin Hardy Strauss Inc. lessened its holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX – Free Report) by 38.3% in the fourth quarter, according to its most recent filing with the SEC. The institutional investor owned 36,470 shares of the biotechnology company’s stock after selling 22,625 shares during the period. Pekin Hardy Strauss Inc.’s holdings in Heron […]

Congress-park-capital
Jw-asset-management
Heron-therapeutics-inc
Needham-company
Tejara-capital-ltd
Pekin-hardy-strauss-inc
Nasdaq
Pekin-hardy-strauss
Heron-therapeutics
Free-report
Hardy-strauss

Pekin Hardy Strauss Inc. Has $62,000 Position in Heron Therapeutics, Inc. (NASDAQ:HRTX)

Pekin Hardy Strauss Inc. lowered its holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX – Free Report) by 38.3% during the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 36,470 shares of the biotechnology company’s stock after selling 22,625 shares during the quarter. […]

Tejara-capital-ltd
Pekin-hardy-strauss-inc
Securities-exchange-commission
Nasdaq
Congress-park-capital
Jw-asset-management
Needham-company
Heron-therapeutics-inc
Pekin-hardy-strauss
Heron-therapeutics
Free-report

Capital One Financial Begins Coverage on Heron Therapeutics (NASDAQ:HRTX)

Capital One Financial started coverage on shares of Heron Therapeutics (NASDAQ:HRTX – Free Report) in a research report sent to investors on Tuesday morning, MarketBeat.com reports. The brokerage issued an overweight rating and a $6.00 price objective on the biotechnology company’s stock. Capital One Financial also issued estimates for Heron Therapeutics’ Q1 2024 earnings at […]

Monaco
Heron-therapeutics-company-profile
Richmond-brothers-inc
Needham-company
Orchard-capital-management
Heron-therapeutics-inc
Panagora-asset-management-inc
Capital-one-financial
Heron-therapeutics
Free-report
One-financial